Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
1 extracted signal · 0 resolved · 1 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 25 Aug 2025, 22:40 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The analysis discusses Lockheed Martin's management team's report of taking charges to address newly identified risks and focusing on growth opportunities. In the most recent quarter, they reported $18 billion in sales, invested $800 million in infrastructure and innovation, and returned $1.3 billion to shareholders. US government sanctions on Turkish entities impacted a program requiring restructuring. The company is focused on providing additional mission capabilities, enhancing logistical support, and extending fleet life for the CMHP program. Servicing helicopters are more lucrative than delivering them. The beta is very low. Using a DCF model, the fair value per share of Lockheed Martin is calculated to be $736.66, while the current market price is $447.20. Recommending the stock to be a buy.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.